The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Abstract
The National Institute of Mental Health (NIMH) convened a meeting in September 2005 to review tobacco use and dependence and smoking cessation among those with mental disorders, especially individuals with anxiety disorders, depression, or schizophrenia. Smoking rates are exceptionally high among these individuals and contribute to the high rates of medical morbidity and mortality in these individuals. Numerous biological, psychological, and social factors may explain these high smoking rates, including the lack of smoking cessation treatment in mental health settings. Historically, "self-medication" and "individual rights" have been concerns used to rationalize allowing ongoing tobacco use and limited smoking cessation efforts in many mental health treatment settings. Although research has shown that tobacco use can reduce or ameliorate certain psychiatric symptoms, overreliance on the self-medication hypothesis to explain the high rates of tobacco use in psychiatric populations may result in inadequate attention to other potential explanations for this addictive behavior among those with mental disorders. A more complete understanding of nicotine and tobacco use in psychiatric patients also can lead to new psychiatric treatments and a better understanding of mental illness. Greater collaboration between mental health researchers and nicotine and tobacco researchers is needed to better understand and develop new treatments for cooccurring nicotine dependence and mental illness. Despite an accumulating literature for some specific psychiatric disorders and tobacco use and cessation, many unstudied research questions remain and are a focus and an emphasis of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research suggests that anxiety and depression are major impediments to smoking cessation,16,17 which is particularly relevant to SLWH given the population’s elevated rates.18”
From Evaluation of an integrated treatment to address smoking cessation and anxiety/depressive symptoms among people living with HIV: Study protocol for a randomized controlled trial (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these known disparities in tobacco smoking and its health consequences for people with BD, there is limited research on the treatment needs and outcomes of quit attempts for this group of smokers.”
From Smokers with bipolar disorder, other affective disorders, and no mental health conditions: Comparison of baseline characteristics and success at quitting in a large 12-month behavioral intervention randomized trial. (2018) · cites this paper as Ziedonis et al., 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, there are high rates of comorbidity between substance abuse and other Axis I conditions [747-749], schizophrenia and bipolar disorder [750], and ASD and mood and anxiety disorders [751].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [749]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, smoking rates have been shown to be significantly higher in the population with anxiety disorders than it is in the nonclinical population, 45.3% and 22.5%, respectively (Lasser et al., 2000; Ziedonis et al., 2008).”
From Nicotine addiction and psychiatric disorders (2015) · cites this paper as Ziedonis et al., 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, depressive and anxiety syndromes are more prevalent among smokers than nonsmokers [6,7], and smokers with these conditions are more likely to be nicotine dependent [4,8].”
From Acceptance and Commitment Therapy Wellness Program for Latine Adults Who Smoke and Have Psychological Distress: Protocol for a Feasibility Study (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Limited integration of factors known to interfere with smoking cessation, such as anxiety and depressive symptoms,16,17 within treatments for SLWH may contribute to quit difficulty and mixed findings.”
The cited source says what the claim attributes to it.
In the citing paper
“Considerable research has assessed the impact of depression and anxiety on cessation outcomes, with a number of studies reporting that depression and anxiety place smokers at increased risk for cessation failure [9-14], with other studies suggesting that the evidence is inconclusive [6,15-18].”
From Acceptance and Commitment Therapy Wellness Program for Latine Adults Who Smoke and Have Psychological Distress: Protocol for a Feasibility Study (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Anxiety disorders co-occur with smoking at rates that exceed those found in the general population (Ziedonis et al., 2008)”
From A qualitative study of the feasibility and acceptability of a smoking cessation program for people living with HIV and emotional dysregulation. (2019) · cites this paper as Ziedonis et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
In search of how people change: Applications to addictive behaviors.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992) · American Psychologist · doi:10.1037/0003-066x.47.9.1102 · Cited by 8,596
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Self-citationTraumatic Events and Posttraumatic Stress Disorder in an Urban Population of Young Adults
Breslau, N. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270028003 · Cited by 2,544
Self-citationVulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. J. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.2.103 · Cited by 1,999
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
A component analysis of cognitive-behavioral treatment for depression.
Jacobson, N. S., Dobson, K. S., Truax, P. A., Addis, M. E., Koerner, K., Gollan, J. K., Gortner, E., & Prince, S. E. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.2.295 · Cited by 1,413
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Self-citationSmoking, stress, and negative affect: Correlation, causation, and context across stages of smoking.
Kassel, J. D., Stroud, L. R., & Paronis, C. A. (2003) · Psychological Bulletin · doi:10.1037/0033-2909.129.2.270 · Cited by 1,113
Research works printed but not linked: 39
- [7]7. al'Absi, M., Hatsukami, D., Davis, G. L., & Wittmers, L. E. (2004). Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking. Drug and Alcohol Dependence, 73(3), 267-278.
- [14]14. Baer, J. S., & Lichtenstein, E. (1988). Cognitive assessment. In: K. A. Donovan, & G. A. Marlatt (Eds.), Assessment of addictive behaviors (pp. 189-213). New York: Guilford Press.
- [28]28. Breslau, N., & Klein, D. F. (1999). Smoking and panic attacks: An epidemiologic investigation. Archives of General Psychiatry, 56(12), 1141-1147.
- [31]31. Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. (1998). Major depression and stages of smoking. A longitudinal investigation. Archives of General Psychiatry, 55(2), 161-166.
- [34]34. Brown, R. A., Kahler, C. W., Zvolensky, M. J., Lejuez, C. W., & Ramsey, S. E. (2001). Anxiety sensitivity: Relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder. Addictive Behaviors, 26(6), 887-899.
- [39]39. Bushnell, P. J., Levin, E. D., Marrocco, R. T., Sarter, M. F., Strupp, B. J., & Warburton, D. M. (2000). Attention as a target of intoxication: Insights and methods from studies of drug abuse. Neurotoxicology and Teratology, 22(4), 487-502.
- [40]40. Calhoun, P. S., Dennis, M. F., & Beckham, J. C. (2007). Emotional reactivity to trauma stimuli and duration of past smoking cessation attempt in smokers with posttraumatic stress disorder. Journal of Experimental and Clinical Psychopharmacology, 15(3), 256-263.
- [45]45. Cinciripini, P. M., Lapitsky, L. G., Wallfisch, A., Van Vunakis, H., & Meyer, W. J. (1995). A placebo controlled evaluation of the effects of buspirone on smoking cessation: Differences between high and low anxiety smokers. Journal of Clinical Psychopharmacology, 15, 182-191.
- [50]50. Cook, J., McFall, M., Calhoun, P. S., & Beckham, J. C. (2007). Posttraumatic stress disorder and relapse to cigarette smoking: A theoretical model. Journal of Traumatic Stress, 20(6), 989-998.
- [61]61. de Leon, J., & Diaz, F. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and smoking behaviors. Schizophrenia Research, 76(2-3), 135-157.
- [64]64. Desai, H. D., Seabolt, J., & Jann, M. W. (2001). Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs, 15(6), 469-494.
- [71]71. Evins, A. E., Cather, C., Rigotti, N. A., Freudenreich, O., Henderson, D. C., & Olm-Shipman, C. M., et al. (2004). Two-year follow-up of a smoking cessation trial in patients with schizo- phrenia: Increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry, 65(3), 307-311; quiz, 452-453.
- [77]77. Freedman, R., Leonard, S., Gault, J. M., Hopkins, J., Cloninger, C. R., & Kaufmann, C. A., et al. (2001). Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7- nicotinic acetylcholine receptor subunit gene (CHRNA7). American Journal of Medical Genetics, 105(1), 20-22.
- [78]78. Fu, S., McFall, M., Saxon, A. J., Beckham, J. C., Carmody, T. P., & Baker, D. G., et al. (2007). Posttraumatic stress disorder and smoking: A systematic review. Nicotine & Tobacco Research, 9(11), 1071-1084.
- [84]84. Gilbert, D. (1995). Smoking: Individual differences, psychopathology and emotion. Washington, DC: Taylor & Francis.
- [87]87. Goff, D. C., Cather, C., Evins, A. E., Henderson, D. C., Freudenreich, O., & Copeland, P. M., et al. (2005). Medical morbidity and mortality in schizophrenia: Guidelines for psychia- trists. Journal of Clinical Psychiatry, 66(2), 183-194; quiz, 147, 273- 284.
- [95]95. Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004). Nicotine dependence and psychiatric disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(11), 1107-1115.
- [98]98. Hajek, P., & Belcher, M. (1991). Improved CO monitors for validating smoking abstinence by expired-air carbon monoxide levels. British Journal of Addiction, 86(8), 1029-1030.
- [107]107. Heishman, S. J. (1998). What aspects of human performance are truly enhanced by nicotine? Addiction, 93(3), 317-320.
- [118]118. Hughes, J. R., & Brandon, T. H. (2003). A softer view of hardening. Nicotine & Tobacco Research, 5(6), 961-962.
- [130]130. Kahler, C. W., Brown, R. A., Strong, D. R., Lloyd-Richardson, E. E., & Niaura, R. (2003). History of major depressive disorder among smokers in cessation treatment: Associations with dysfunctional attitudes and coping. Addictive Behaviors, 28(6), 1033-1047.
- [134]134. Kaufmann, C. A., Suarez, B., Malaspina, D., Pepple, J., Svrakic, D., & Markel, P. D., et al. (1998). NIMH Genetics Initiative Millenium Schizophrenia Consortium: Linkage analysis of African-American pedigrees. American Journal of Medical Genetics, 81(4), 282-289.
- [145]145. Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. The Journal of the American Medical Association, 284(20), 2606-2610.
- [159]159. Liu, H., Heath, S. C., Sobin, C., Roos, J. L., Galke, B. L., & Blundell, M. L., et al. (2002). Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 99(6), 3717-3722.
- [164]164. Marlatt, G. A., & Gordon, J. R. (Eds.) (1980). Determinants of relapse. Implications for behavior change. New York: Brunner/Mazel.
- [177]177. Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006). Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Molecular Pharmacology, 70(3), 801-805.
- [184]184. Olincy, A., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., & Allensworth, D., et al. (2006). Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Archives of General Psychiatry, 63(6), 630-638.
- [196]196. Rao, U. (2006). Links between depression and substance abuse in adolescents neurobiological mechanisms. American Journal of Preventive Medicine, 31(6 Suppl. 1), 161-174.
- [201]201. Riley, B. P., Makoff, A., Mogudi-Carter, M., Jenkins, T., Williamson, R., & Collier, D., et al. (2000). Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. American Journal of Medical Genetics, 96(2), 196-201.
- [206]206. Sacco, K. A., Termine, A., Seyal, A., Dudas, M. M., Vessicchio, J. C., & Krishnan-Sarin, S., et al. (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: Involvement of nicotinic receptor mechanisms. Archives of General Psychiatry, 62(6), 649-659.
- [208]208. Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002). Nicotinic- serotonergic interactions in brain and behavior. Pharmacology, Biochemistry, and Behavior, 71(4), 795-805.
- [219]219. Stassen, H. H., Bridler, R., Hagele, S., Hergersberg, M., Mehmann, B., & Schinzel, A., et al. (2000). Schizophrenia and smoking: Evidence for a common neurobiological basis? American Journal of Medical Genetics, 96(2), 173-177.
- [223]223. Steinberg, M. L., Williams, J. M., & Ziedonis, D. M. (2004). Financial implications of cigarette smoking among individuals with schizo- phrenia. Tobacco Control, 13(2), 206.
- [234]234. Tremblay, L. K., Naranjo, C. A., Cardenas, L., Herrmann, N., & Busto, U. E. (2002). Probing brain reward system function in major depressive disorder: Altered response to dextroamphetamine. Archives of General Psychiatry, 59(5), 409-416.
- [245]245. Williams, J. M., & Hughes, J. R. (2003). Pharmacotherapy treatments for tobacco dependence among smokers with mental illness. Psychiatric Annals, 22(7), 457-466.
- [249]249. Wills, T. A., & Shiffman, S. (1985). Coping and substance use: A conceptual framework. In: S. Shifffman, & T. A. Wills (Eds.), Coping and substance use (pp. 3-24). Orlando, FL: Academic Press.
- [262]262. Ziedonis, D., Williams, J., Steinberg, M. L., Smelson, D., Sussner, B., Foulds, J., Krejci, J., & Violette, N. (2005). Addressing tobacco dependence amongst individuals with a psychiatric disorder: A neglected epidemic of major clinical and public health concern. In: S. L. Isaacs (Ed), VA in the vanguard: Building on success in smoking cessation (pp. 141-170). Washington, DC: Department of Veterans Affairs.
- [276]276. Zvolensky, M. J., Schmidt, N. B., & McCreary, B. T. (2003). The impact of smoking on panic disorder: An initial investigation of a pathoplastic relationship. Journal of Anxiety Disorders, 17, 447-460.
- [278]278. Zvolensky, M. J., Vujanovic, A. A., Bonn-Miller, M. O., Bernstein, A., Yartz, A. R., & Gregor, K. L., et al. (2007). Incremental validity of anxiety sensitivity in terms of motivation to quit, reasons for quitting, and barriers to quitting among community-recruited smokers. Nicotine & Tobacco Research, 9(9), 965-975.
Cited by
Sorted by citations
Benowitz, N. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809890 · Cited by 1,508
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Review: Inequalities in healthcare provision for people with severe mental illness
Lawrence, D., & Kisely, S. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382058 · Cited by 649
Smoking and mental illness: results from population surveys in Australia and the United States
Lawrence, D., Mitrou, F., & Zubrick, S. R. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-285 · Cited by 517
Schroeder, S. A., & Morris, C. D. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103701 · Cited by 349
Metadata
- Authors
- Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., Calhoun, P. S., & Riley, W. T.
- Affiliations
- UMass Memorial Health Care (US)
- Northwestern University (US)
- Duke University (US)
- University of Vermont (US)
- University of Colorado Health (US)
- University of Pennsylvania (US)
- Michigan State University (US)
- Brown University (US)
- University of Toronto (CA)
- Rutgers, The State University of New Jersey (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-01
- Volume
- 10
- Issue
- 12
- Pages
- 1691-1715
- ISSN
- 1462-2203 (ISSN-L)
- 1469-994X
- OpenAlex
- W2126866313
- Semantic Scholar
- 1098de69bc87efcdfb0ceacacd784724606d74d2
- Cited by
- 735
- References
- 246
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 18 · 2023: 42 · 2022: 27 · 2021: 30 · 2020: 48 · 2019: 28 · 2018: 50 · 2017: 32 · 2016: 62 · 2015: 65 · 2014: 59 · 2013: 50 · 2012: 62
- FWCI
- 28.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nicotine & Tobacco Research (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Office of Research and Development
- State of New Jersey Department of Health
- National Alliance for Research on Schizophrenia and Depression
- Missouri Department of Health and Senior Services
- University of Toronto
- National Institutes of Health (5k24da016388-10, 5r01da018734-03)
- National Institute on Alcohol Abuse and Alcoholism (R01AA015950, AA015950)
- National Institute of Mental Health (R01MH076672, MH 076629-01, MH076629, MH050787-11, R01MH050787, MH076672-01A1, R01MH076629)
- National Institute on Drug Abuse (DA020705, R03DA016307, DA015537, DA 16307-01, DA019704, DA016738, R01DA020705, R21DA019704, R01DA016738, DA16611, R01DA017947, DA016388, R01DA013672, DA023190, DA018734--01A1, K08DA017145, DA017145, R01DA015537, R01DA023190, R01DA014039, DA13672, DA14039, DA017947, K02DA016611)
- National Cancer Institute (R01CA096836, CA081595, R01CA081595, CA096836, R01CA109250, CA109250)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- tobacco use, smoking cessation, nicotine dependence, mental illness, anxiety disorders, depression, schizophrenia, self-medication hypothesis
- MeSH terms
- Anxiety Disorders, Mental Disorders, Depression, Humans, National Institute of Mental Health (U.S.), Primary Prevention, Risk Factors, Schizophrenia, Smoking, Social Environment, Tobacco Use Disorder, United States, Comorbidity, Prevalence, Smoking Cessation, Self Efficacy, Mentally Ill Persons, Persons with Psychiatric Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
